Ryvu Therapeutics (RVU) Financial Results
Report publication dates, analyst consensus, and how Ryvu Therapeutics' share price reacted to previous earnings — all in one place, in English.
When Ryvu Therapeutics Releases Earnings
The date of Ryvu Therapeutics' next earnings release is not yet known. Companies usually announce it a few weeks before the report — the in-app calendar updates automatically when the date becomes available.
Insider Transactions: Ryvu Therapeutics
Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.
Analyst forecasts for upcoming periods
The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.
| Period | EPS estimate | EPS a year ago | Change | Revenue forecast | Analysts |
|---|---|---|---|---|---|
| Current year | -1.88 | -4.40 | +57.27% | 92.00M PLN | 2 |
| Next year | 2.44 | -1.88 | +229.79% | 133.63M PLN | 2 |
Revenue and margins quarter by quarter
Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.
| Quarter | Revenue | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|
| June 30, 2026 | 11.99M PLN | 70.61% | -139.58% | -108.92% |
| March 31, 2026 | 16.95M PLN | 75.63% | -73.19% | -74.61% |
| December 31, 2025 | 18.00M PLN | 77.34% | -93.31% | -97.72% |
| September 30, 2025 | 14.92M PLN | 75.61% | -170.41% | -165.62% |
| June 30, 2025 | 12.40M PLN | 72.77% | -219.58% | -271.37% |
Who Reports in the Coming Weeks
Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.
About Ryvu Therapeutics
Ryvu Therapeutics S.A. is listed on the Warsaw Stock Exchange under the ticker RVU and is headquartered in Poland. The company belongs to the healthcare sector (industry: Biotechnology).
- Ticker: RVU (trading symbol: RVU.WA)
- Exchange: Warsaw Stock Exchange
- Trading currency: PLN
- Sector: healthcare
- Number of Analysts Providing Estimates: 5
- 52-Week Range: 0.00 – 31.90
- Company website: https://ryvu.com
Frequently Asked Questions
When does Ryvu Therapeutics release earnings?
The date of the next release has not yet been announced. The Portevo earnings calendar updates automatically when the company provides the date.
What is Ryvu Therapeutics' ticker symbol?
RVU — on the Warsaw Stock Exchange. You may also see RVU.WA on quote services.
Where can I find Ryvu Therapeutics' financial results in English?
On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.
Other companies in the healthcare sector
A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.
Related
Track Ryvu Therapeutics on Portevo
The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.
Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.
Your entire portfolio, company earnings, and insider trades in one place
Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.
- Portfolio with Net Profit After Costs
- Earnings Calendar for Your Companies
- Pelosi, Trump, and CEO Trades on a Chart
- Works in Browser and on iPhone
No credit card required. A demo portfolio is available immediately; create your own by uploading a report.




